Brentview Investment Management LLC Invests $3.41 Million in Marsh & McLennan Companies, Inc. $MRSH

Brentview Investment Management LLC bought a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 18,363 shares of the financial services provider’s stock, valued at approximately $3,407,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Numerai GP LLC grew its position in Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after buying an additional 33,729 shares in the last quarter. Swiss Life Asset Management Ltd grew its position in Marsh & McLennan Companies by 9.5% in the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after buying an additional 11,648 shares in the last quarter. Rockland Trust Co. grew its position in Marsh & McLennan Companies by 801.6% in the 3rd quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock valued at $2,433,000 after buying an additional 10,734 shares in the last quarter. Barclays PLC grew its position in Marsh & McLennan Companies by 41.7% in the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after buying an additional 647,987 shares in the last quarter. Finally, Bridges Investment Management Inc. grew its position in Marsh & McLennan Companies by 4.4% in the 3rd quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock valued at $15,356,000 after buying an additional 3,177 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Trading Down 0.1%

MRSH stock opened at $159.73 on Monday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28. Marsh & McLennan Companies, Inc. has a one year low of $157.74 and a one year high of $235.78. The stock has a market capitalization of $77.17 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 2.33 and a beta of 0.62. The firm’s 50-day moving average price is $164.87.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company had revenue of $7.30 billion during the quarter. The firm’s revenue was up 7.6% compared to the same quarter last year. On average, equities research analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Analysts Set New Price Targets

MRSH has been the subject of a number of research analyst reports. Wells Fargo & Company cut their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a report on Thursday, April 9th. Morgan Stanley cut their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a report on Monday, April 6th. JPMorgan Chase & Co. cut their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a report on Thursday, April 9th. Mizuho cut their price target on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a report on Monday, April 13th. Finally, Weiss Ratings downgraded shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus target price of $203.56.

Insider Buying and Selling

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the company’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at approximately $21,411,456.30. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.